AT1 5.00% 2.1¢ atomo diagnostics limited

AT1 FY21 - General Discussion + FA, page-1185

  1. 1,209 Posts.
    lightbulb Created with Sketch. 646
    Hiya, I see other replies to your Q already. Here is the info I posted about Lumos-Diasorin ann in the Media thread:=> Post #: 52306043

    It doesn't impact AT1-FebriDx test supply in any way. It does make LumosDx a stronger company with an new channel for cashflow via its OEM assay dev biz.

    Which is good for AT1 if its partners grow stronger, have good amts of cash to put into FebriDx expansion + any future test dev collaborations.
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.